Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This gives us tighter control over formulation quality, fulfillment accuracy, packaging standards, storage conditions, and customer experience
Long-term safety data for subcutaneous injection is limited
Hims, a telehealth company that sells direct-to-consumer finasteride and GLP-1s, has signaled that it will move to sell the controversial substances should they be approved after acquiring a peptide manufacturing facility in 2025
28.2% for controls (Pickart & Margolina, 2018)
US$ 24.15
US$ 25.08
US$ 22.58
US$ 23.43
